Biology of presenilins as causative molecules for Alzheimer disease

Clinical Genetics

Volumn 55, Issue 4, 1999, Pages 219-225

  Nishimura, Masaki ^a   Yu, Gang ^a   St George Hyslop, Peter H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

amyloid precursor protein; catenin; Alzheimer disease; Notch 1; Presenilin

Indexed keywords

AMYLOID BETA PROTEIN; BETA CATENIN; CADHERIN; MEMBRANE PROTEIN; PRESENILIN 1; PRESENILIN 2; PROTEIN PRECURSOR;

ALZHEIMER DISEASE; APOPTOSIS; AUTOSOMAL DOMINANT INHERITANCE; COMPLEX FORMATION; HUMAN; HUMAN CELL; MISSENSE MUTATION; MORPHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; BETA CATENIN; CYTOSKELETAL PROTEINS; HUMANS; MEMBRANE PROTEINS; MOLECULAR WEIGHT; MUTATION, MISSENSE; PRESENILIN-1; PRESENILIN-2; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 0033005161     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.1999.550401.x     Document Type: Review

References (52)

1. St George-Hyslop PH, Haines JL, Farrer LA, Polinsky R, Van Broeckhoven C et al. Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. FAD Collaborative Study Group. Nature 1990: 347: 194-197.
2. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995: 375: 754-760.
3. Rogaev EI, Sherrington R, Wu C, Levesque G et al. Analysis of the 5′ sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer disease. Genomics 1997: 40: 415-424.
4. De Strooper B, Beullens M, Contreras B, Levesque L, Craessaerts K et al. Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins. J Biol Chem 1997: 272: 3590-3598.
5. Lehmann S, Chiesa R, Harris DA. Evidence for a six-transmembrane domain structure of presenilin 1. J Biol Chem 1997: 272: 12047-12051.
6. Doan A, Thinakaran G, Borchelt DR, Slunt HH, Ratovitsky T et al. Protein topology of presenilin 1. Neuron 1996: 17: 1023-1030.
7. Thinakaran G, Borchelt DR, Lee MK, Slunt HH, Spitzer L et al. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 1996: 17: 181-190.
8. Podlisny MB, Citron M, Amarante P, Sherrington R, Xia W et al. Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N-and C-terminal fragments in normal and Alzheimer brain tissue. Neurobiol Dis 1997: 3: 325-337.
9. Fraser PE, Levesque G, Yu G, Mills LR, Thirlwell J et al. Presenilin 1 is actively degraded by the 26S proteasome. Neurobiol Aging 1998: 19 (Suppl): S19-21.
10. Thinakaran G, Regard JB, Bouton CM, Harris CL, Price DL et al. Stable association of presenilin derivatives and absence of presenilin interactions with APP. Neurobiol Dis 1998: 4: 438-453.
11. Kim TW, Pettingell WH, Jung YK, Kovacs DM, Tanzi RE. Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science 1997: 277: 373-376.
12. Grunberg J, Walter J, Loetscher H, Deuschle U, Jacobsen H, Haass C. Alzheimer's disease associated presenilin-1 holoprotein and its 18-20 kDa C-terminal fragment are death substrates for proteases of the caspase family. Biochemistry 1998: 37: 2263-2270.
13. Brockhaus M, Grunberg J, Rohrig S, Loetscher H, Wittenburg N et al. Caspase-mediated cleavage is not required for the activity of presenilins in amyloidogenesis and NOTCH signaling. Neuroreport 1998: 9: 1481-1486.
14. Vito P, Ghayur T, D'Adamio L. Generation of anti-apoptotic presenilin-2 polypeptides by alternative transcription, proteolysis, and caspase-3 cleavage. J Biol Chem 1997: 272: 28315-28320.
15. Capell A, Grunberg J, Pesold B, Diehlmann A, Citron M et al. The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex. J Biol Chem 1998: 273: 3205-3211.
16. Yu G, Chen F, Levesque G, Nishimura M, Zhang DM et al. The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains β-catenin. J Biol Chem 1998: 273: 16470-16475.
17. Lee SJ, Liyanage U, Bickel PE, Xia W, Lansbury PT Jr, Kosik KS. A detergent-insoluble membrane compartment contains Aβ in vivo. Nature Med 1998: 4: 730-734.
18. Steiner H, Capell A, Pesold B, Citron M, Kloetzel PM et al. Expression of Alzheimer's disease-associated presenilin-1 is controlled by proteolytic degradation and complex formation. J Biol Chem 1998: 273: 32322-32331.
19. Thinakaran G, Harris CL, Ratovitski T, Davenport F, Slunt HH et al. Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors. J Biol Chem 1997: 272: 28415-28422.
20. Tomita T, Tokuhiro S, Hashimoto T, Aiba K, Saido TC, Maruyama K, Iwatsubo T. Molecular dissection of domains in mutant presenilin 2 that mediate overproduction of amyloidogenic forms of amyloid β peptides. Inability of truncated forms of PS2 with familial Alzheimer's disease mutation to increase secretion of Aβ42. J Biol Chem 1998: 273: 21153-21160.
21. Zhou J, Liyanage U, Medina M, Ho C, Simmons AD, Lovett M, Kosik KS. Presenilin 1 interaction in the brain with a novel member of the Armadillo family. Neuroreport 1997: 8: 2085-2090.
22. Levesque G, Yu G, Nishimura M, Zhang DM, Levesque L, et al. Presenilins interact with armadillo proteins including neural specific plakophilin related protein and β-catenin. J Neurochem, in press.
23. Tesco G, Kim TW, Diehlmann A, Beyreuther K, Tanzi RE. Abrogation of the presenilin 1/β-catenin interaction and preservation of the heterodimeric presenilin 1 complex following caspase activation. J Biol Chem 1998: 273: 33909-33914.
24. Weidemann A, Paliga K, Durrwang U, Czech C, Evin G, Masters CL, Beyreuther K. Formation of stable complexes between two Alzheimer's disease gene products: presenilin-2 and β-amyloid precursor protein. Nature Med 1997: 3: 328-332.
25. Xia W, Zhang J, Perez R, Koo EH, Selkoe DJ. Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer disease. Proc Natl Acad Sci USA 1997: 94: 8208-8213.
26. L'Hernault SW, Arduengo PM. Mutation of a putative sperm membrane protein in Caenorhabditis elegans prevents sperm differentiation but not its associated meiotic divisions. J Cell Biol 1992: 119: 55-68.
27. De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 1998: 391: 387-390.
28. Xia W, Zhang J, Ostaszewski BL, Kimberly WT, Seubert P et al. Presenilin 1 regulates the processing of β-amyloid precursor protein C-terminal fragments and the generation of amyloid β-protein in endoplasmic reticulum and Golgi. Biochemistry 1998: 37: 16465-16471.
29. Naruse S, Thinakaran G, Luo JJ, Kusiak JW, Tomita T et al. Effects of PS1 deficiency on membrane protein trafficking in neurons. Neuron 1998: 21: 1213-1221.
30. Nishimura M, Yu G, Levesque G, Zhang DM, Ruel L et al. Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of β-catenin, a component of the presenilin protein complex. Nature Med 1999: 5: 164-169.
31. Levitan D, Greenwald I. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 1995: 377: 351-354.
32. Shen J, Bronson RT, Chen DF, Xia W, Selkoe DJ, Tonegawa S. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 1997: 89: 629-639.
33. Wong PC, Zheng H, Chen H, Becher MW, Sirinathsinghji DJ et al. Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature 1997: 387: 288-292.
34. Wolozin B, Iwasaki K, Vito P, Ganjei JK, Lacana E et al. Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science 1996: 274: 1710-1713.
35. Davis JA, Naruse S, Chen H, Eckman C, Younkin S et al. An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos. Neuron 1998: 20: 603-609.
36. Qian S, Jiang P, Guan XM, Singh G, Trumbauer ME et al. Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates Aβ1 1-42/43 expression. Neuron 1998: 20: 611-617.
37. Levitan D, Doyle TG, Brousseau D, Lee MK, Thinakaran G et al. Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc Natl Acad Sci USA 1996: 93: 14940-14944.
38. Baumeister R, Leimer U, Zweckbronner I, Jakubek C, Grunberg J, Haass C. Human presenilin-1, but not familial Alzheimer's disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing. Genes Funct 1997: 1: 149-159.
39. Martins RN, Turner BA, Carroll RT, Sweeney D, Kim KS et al. High levels of amyloid-β protein from S182 (Glu246) familial Alzheimer's cells. Neuroreport 1995: 7: 217-220.
40. Scheuner D, Eckman C, Jensen M, Song X, Citron M et al. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med 1996: 2: 864-870.
41. Duff K, Eckman C, Zehr C, Yu X, Prada CM et al. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 1996: 383: 710-713.
42. Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron 1996: 17: 1005-1013.
43. Citron M, Westaway D, Xia W, Carlson G, Diehl T et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nature Med 1997: 3: 67-72.
44. Tamaoka A, Fraser PE, Ishii K, Sahara N, Ozawa K et al. Amyloid-β-protein isoforms in brain of subjects with PS1-linked, βAPP-linked and sporadic Alzheimer disease. Brain Res Mol Brain Res 1998: 56: 178-185.
45. Vito P, Wolozin B, Ganjei JK, Iwasaki K, Lacana E, D'Adamio L. Requirement of the familial Alzheimer's disease gene PS2 for apoptosis. Opposing effect of ALG-3. J Biol Chem 1996: 271: 31025-31028.
46. Deng G, Pike CJ, Cotman CW. Alzheimer-associated presenilin-2 confers increased sensitivity to apoptosis in PC12 cells. FEBS Lett 1996: 397: 50-54.
47. Zhang Z, Hartmann H, Do VM, Abramowski D, Sturchler-Pierrat C et al. Destabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature 1998: 395: 698-702.
48. Takashima A, Murayama M, Murayama O, Kohno T, Honda T et al. Presenilin 1 associates with glycogen synthase kinase-3β and its substrate tau. Proc Natl Acad Sci USA 1998: 95: 9637-9641.
49. Irving NG, Millaer CCJ. Tau phosphorylation in cells transfected with wild-type or Alzheimer's disease mutant presenilin 1. Neurosci Lett 1997: 222: 71-74.
50. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995: 376: 775-778.
51. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995: 269: 973-977.
52. Kakizuka A. Protein precipitation: a common etiology in neurodegenerative disorders? Trends Genet 1998: 14: 396-402.